Athenex Pharma Solutions, LLC 2022-03-30 Health serious FDA
Health · FDA · Recall #FDA-D-0707-2022
Norepinephrine Bitartrate Injection 16 mg per 250 mL added to 0.9% Sodium Chloride, 16… Recall
Issued March 30, 2022 · Athenex Pharma Solutions, LLC
In March 2022, Athenex Pharma Solutions, LLC recalled the Norepinephrine Bitartrate Injection 16 mg per 250 mL added to 0.9% Sodium Chloride, 16…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Defective container
What you should do
- 1 Stop using Norepinephrine Bitartrate Injection 16 mg per 250 mL added to 0.9% Sodium Chloride, 16… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Athenex Pharma Solutions, LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Athenex Pharma Solutions, LLC
- Category
- Health
- Recall date
- March 30, 2022
- Units affected
- Not reported
- Sold at
- USA nationwide.
- Recall number
- FDA-D-0707-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Athenex Pharma Solutions, LLC has 6 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.